Fertility sparing surgery in treatment of early stage of cervical | 8106
Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Fertility sparing surgery in treatment of early stage of cervical cancer

International conference on Human Papillomavirus

October 20-21, 2016 Chicago, USA

Aleksandar Stefanovic

University of Belgrade, Serbia

Scientific Tracks Abstracts: J Antivir Antiretrovir

Abstract :

Standard surgical approach to invasive cervical cancer carries risks of unfulfilled reproductive plans and morbidity, which could influence quality of life to a greater extent. Radical trachelectomy is a fertility sparing procedure with the aim to preserve reproductive potential of the patient with unchanged oncologic outcome. The procedure can be performed by vaginal or abdominal approach. Abdominal trachelectomy offers greater radicality concerning the parametrial resection with an easier learning curve, although studies demonstrate slightly lower reproductive success. Vaginal radical trachelectomy is combined with minimally invasive lymphadenectomy (laparoscopic or robotic). The procedure is applied to patients with early-stages of cervical cancer, FIGO staged as Ia1, Ia2 and smaller Ib1 tumors. Since the procedure is combined with an ex-tempore histologic analysis, organization and experience of team is of crucial importance. Oncologic outcome is excellent and comparable to standard procedure. Fertility rates are between 40 and 70% with increased rates of pregnancies achieved by assisted reproductive procedures (about 1/3). The rate of pregnancy complication is higher and includes increased rates of abortions, preterm deliveries, chorioamnionitis and cesarean sections. In an attempt to further decrease morbidity and to optimize reproductive outcome, some institutions perform less radical approach conisation or amputation of cervix, preceded by pelvic lympadenectomy. Novel approaches include sentinel node biopsies and neoadjuvant chemotherapy followed by fertility sparing procedures. Since the oncologic safety of these procedures is yet to be determined, for now these procedures have to be considered as experimental. More studies, concerning the safety of above mentioned procedures are needed, before they can fully be utilized in routine practice.

Biography :

Aleksandar Stefanovic has completed his PhD from University in Belgrade, Serbia. He is the Director of Clinic of Ob/Gyn, Clinical Center of Serbia and the President of Association of Gynecologist and Obstetricians of Serbia, Montenegro and Republic of Srpska. He has published more than 35 papers in reputed journals and has been serving as an Editorial Board Member of repute.